83.94
0.47 (0.56%)
Previous Close | 83.47 |
Open | 83.07 |
Volume | 117,705 |
Avg. Volume (3M) | 906,377 |
Market Cap | 11,429,859,328 |
Price / Earnings (TTM) | 135.39 |
Price / Earnings (Forward) | 25.25 |
Price / Sales | 4.78 |
Price / Book | 2.91 |
52 Weeks Range | |
Earnings Date | 18 Feb 2025 - 24 Feb 2025 |
Profit Margin | 3.69% |
Operating Margin (TTM) | 17.67% |
Diluted EPS (TTM) | 0.620 |
Quarterly Revenue Growth (YOY) | 63.10% |
Quarterly Earnings Growth (YOY) | 5,094.00% |
Total Debt/Equity (MRQ) | 13.18% |
Current Ratio (MRQ) | 2.51 |
Operating Cash Flow (TTM) | 414.97 M |
Levered Free Cash Flow (TTM) | 473.36 M |
Return on Assets (TTM) | 4.73% |
Return on Equity (TTM) | 2.22% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Mixed | Mixed |
Medical Devices (Global) | Mixed | Mixed | |
Stock | Globus Medical, Inc. | Bullish | Bullish |
AIStockmoo Score
Analyst Consensus | 4.0 |
Insider Activity | NA |
Price Volatility | -0.5 |
Technical Moving Averages | 1.5 |
Technical Oscillators | 2.0 |
Average | 1.75 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Mid Growth |
% Held by Insiders | 0.62% |
% Held by Institutions | 82.10% |
52 Weeks Range | ||
Price Target Range | ||
High | 115.00 (Roth MKM, 37.00%) | Buy |
Median | 96.00 (14.37%) | |
Low | 90.00 (Truist Securities, 7.22%) | Hold |
Average | 97.30 (15.92%) | |
Total | 8 Buy, 2 Hold | |
Avg. Price @ Call | 83.65 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Canaccord Genuity | 10 Jan 2025 | 101.00 (20.32%) | Buy | 87.07 |
09 Dec 2024 | 92.00 (9.60%) | Buy | 82.92 | |
B of A Securities | 09 Jan 2025 | 97.00 (15.56%) | Hold | 86.55 |
06 Nov 2024 | 80.00 (-4.69%) | Sell | 82.71 | |
Truist Securities | 18 Dec 2024 | 90.00 (7.22%) | Hold | 81.78 |
Roth MKM | 17 Dec 2024 | 115.00 (37.00%) | Buy | 83.42 |
06 Nov 2024 | 100.00 (19.13%) | Buy | 82.71 | |
BTIG | 12 Dec 2024 | 91.00 (8.41%) | Buy | 82.71 |
Wells Fargo | 11 Dec 2024 | 95.00 (13.18%) | Buy | 82.94 |
06 Nov 2024 | 88.00 (4.84%) | Buy | 82.71 | |
Morgan Stanley | 02 Dec 2024 | 100.00 (19.13%) | Buy | 83.90 |
11 Nov 2024 | 83.00 (-1.12%) | Hold | 81.99 | |
Piper Sandler | 06 Nov 2024 | 100.00 (19.13%) | Buy | 82.71 |
RBC Capital | 06 Nov 2024 | 92.00 (9.60%) | Buy | 82.71 |
Stifel | 06 Nov 2024 | 92.00 (9.60%) | Buy | 82.71 |
Show more |
No data within this time range.
Date | Type | Details |
---|---|---|
08 Jan 2025 | Announcement | Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results |
22 Nov 2024 | Announcement | Globus Medical Launches ExcelsiusHub™ Navigation System |
05 Nov 2024 | Announcement | Globus Medical Reports Third Quarter 2024 Results |
18 Oct 2024 | Announcement | Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting |
15 Oct 2024 | Announcement | Globus Medical Schedules Third Quarter Earnings Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |